	Koszty Sprzedaży I Administracji		Data
Acadia Pharmaceuticals	USD 146.73M	21.82M	2025-12
Alnylam Pharmaceuticals	USD 285.06M	22.47M	2025-12
Amgen	USD 1.94B	237M	2025-12
BioCryst Pharmaceuticals	USD 80.47M	15.39M	2024-12
Biogen	USD 545.2M	38.6M	2025-09
BioMarin Pharmaceutical	USD 322.21M	98.79M	2025-12
Cytokinetics	USD 91.72M	67.02M	2025-12
Daiichi Sankyo	JPY 228.23B	39.15B	2025-12
Enanta Pharmaceuticals	USD -1.05	0.31	2024-12
Esperion Therapeutics	USD 39.98M	4.21M	2024-09
Gilead Sciences	USD 1.78B	425M	2025-12
Incyte	USD 390.41M	61.33M	2025-12
Ionis Pharmaceuticals	USD 130M	43.43M	2025-12
Ironwood Pharmaceuticals	USD 33.33M	2.78M	2024-12
Karyopharm Therapeutics	USD 27.19M	442K	2024-12
Novartis	USD 3.31B	134M	2025-09
Pfizer	USD 4.08B	894M	2025-12
PTC Therapeutics	USD 87.2M	3.15M	2025-12
Puma Biotechnology	USD 16.82M	8.15M	2024-09
Roche Holding	CHF 7.28B	3.99B	2025-12
Sangamo BioSciences	USD 9.64M	1.83M	2024-06
Sarepta Therapeutics	USD 105.38M	28.27M	2025-12
TG Therapeutics	USD 50.73M	12.64M	2025-12
Ultragenyx Pharmaceutical	USD 89M	2.38M	2025-12
Vertex Pharmaceuticals	USD 487M	41.9M	2025-12
Xencor	USD 17.04M	70.74M	2025-12

PTC Therapeutics Koszty Sprzedaży I Administracji - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Mar 2026.